Comparison of quantitative FDG-PET and MRI in anti-LGI1 autoimmune encephalitis
Open Access
- 2 June 2023
- journal article
- research article
- Published by Springer Nature in Neuroradiology
- Vol. 65 (8) , 1225-1238
Abstract
Objectives: Anti-leucine glioma-inactivated protein 1 (anti-LGI1) autoimmune encephalitis (AE) presents as subacute memory loss, behavioral changes, and seizures. Diagnosis and treatment delays can result in long term sequelae, including cognitive impairment. 18F-FDG PET/CT may be more sensitive than MRI in patients with AE. Our objective was to determine if anti-LGI1 is associated with a distinct pattern of FDG uptake and whether this pattern persists following treatment. Methods: Nineteen18F-FDG PET/CT brain scans (13 pre-treatment, 6 convalescent phase) for 13 patients with anti-LGI1 were studied using NeuroQ™ and CortexID™. The sensitivity of the PET images was compared to MRI. The Z scores of 47 brain regions between the pre-treatment and next available follow-up images during convalescence were compared. Results: All 18F-FDG PET/CT scans demonstrated abnormal FDG uptake, while only 6 (42.9%) pre-treatment brain MRIs were abnormal. The pre-treatment scans demonstrated hypermetabolism in the bilateral medial temporal cortices, basal ganglia, brain stem, and cerebellum and hypometabolism in bilateral medial and mid frontal, cingulate, and parietotemporal cortices. Overall, the brain uptake during convalescence showed improvement of the Z scores towards 0 or normalization of previous hypometabolic activity in medial frontal cortex, inferior frontal cortex, Broca’s region, parietotemporal cortex, and posterior cingulate cortex and previous hypermetabolic activity in medial temporal cortices, caudate, midbrain, pons and cerebellum. Conclusions: Brain FDG uptake was more commonly abnormal than MRI in the pre-treatment phase of anti-LGI1, and patterns of dysmetabolism differed in the pre-treatment and convalescent phases. These findings may expedite the diagnosis, treatment, and monitoring of anti-LGI1 patients.Keywords
Funding Information
- National Institute of Biomedical Imaging and Bioengineering (T32EB006351)
This publication has 21 references indexed in Scilit:
- Diagnostic Value of18F-FDG PET/CT Versus MRI in the Setting of Antibody-Specific Autoimmune EncephalitisJournal of Nuclear Medicine, 2017
- Anti-LGI1 encephalitisNeurology, 2016
- A clinical approach to diagnosis of autoimmune encephalitisThe Lancet Neurology, 2016
- Dystonia as a network disorder: What is the role of the cerebellum?Neuroscience, 2014
- Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody typesJournal of Neurology, 2013
- The functional neuroanatomy of dystoniaNeurobiology of Disease, 2011
- Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitisAnnals of Neurology, 2010
- Defining the expression pattern of the LGI1 gene in BAC transgenic miceMammalian Genome, 2007
- The LGI1/Epitempin gene encodes two protein isoforms differentially expressed in human brainJournal of Neurochemistry, 2006
- The Epilepsy-Linked Lgi1 Protein Assembles into Presynaptic Kv1 Channels and Inhibits Inactivation by Kvβ1Neuron, 2006